Cite
HARVARD Citation
Cartwright, D. et al. (n.d.). 510 Niraparib outcomes in brca wild-type platinum sensitive recurrent ovarian cancer: a comparison of real-world data to the nova trial. International journal of gynecological cancer. pp. A85-A86. [Online].